BioStem Technologies, Inc. cotiza a 2.25 USD y tiene una capitalización bursátil de $42M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC,…
| Periodo | 2026-11 | 2026-05 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | — | $-0.52 | $0.06 | $0.11 |
| Estimado | $0.10 | $-0.28 | — | $0.32 |
| Sorpresa | — | -85.7% | — | -65.6% |
| Métrica | BSEM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | — | -32.0% | — |
| Current Ratio | 4.12 | 2.84 | +1.28 |
| Debt / Equity | — | 0.28 | — |